Philip Kusk

Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer’s disease patients: application of a second-generation encapsulated cell biodelivery device

Helga Eyjolfsdottir, Maria Eriksdotter, Bengt Linderoth et al. · Alzheimer s Research & Therapy · 2016 · 144 citations · Full text

Engineering, Neurology, Neuroscience +16

Targeted delivery of nerve growth factor via encapsulated cell biodelivery in Alzheimer disease: a technology platform for restorative neurosurgery

Lars U. Wahlberg, Göran Lind, Per Almqvist et al. · Journal of neurosurgery · 2012 · 130 citations

Pharmacy, Neuroscience, Neurosurgery +17

Generation of a synthetic mammalian promoter library by modification of sequences spacing transcription factor binding sites

Jens Tornøe, Philip Kusk, Teit E. Johansen et al. · Gene · 2002 · 98 citations

Life Sciences, Molecular Biology, Molecular Genetics +14

Efficient in vivo protection of nigral dopaminergic neurons by lentiviral gene transfer of a modified Neurturin construct

Lone Fjord‐Larsen, Jens Leander Johansen, Philip Kusk et al. · Experimental Neurology · 2005 · 93 citations

Life Sciences, Biotechnology, Neuroscience +16

Serum osteoprotegerin (OPG) and the A163G polymorphism in the OPG promoter region are related to peripheral measures of bone mass and fracture odds ratios

Henrik L. J�rgensen, Philip Kusk, Bente Kühn Madsen et al. · Journal of Bone and Mineral Metabolism · 2004 · 84 citations

Medicine, Genetics, Molecular Genetics +16